Newstral
Article
jdsupra.com on 2017-08-16 14:44
FDA Approving Orphan Drugs At A Record Pace
Related news
- MThe FDA is approving more drugs with less evidence they work: studymarketwatch.com
- MAstraZeneca: FDA gives orphan drug status to two liver cancer drugsmarketwatch.com
- Orphan Drugs Are Your FriendMother Jones
- Lundbeck's Carnexiv gets FDA orphan drug statusdailyherald.com
- SA biotech gets FDA orphan drug designationbizjournals.com
- FDA on pace for a Record Number of Breakthrough Devices in 2023jdsupra.com
- Orphan drugs for rare diseases soarBoston Herald
- FDA panel recommends approving new drug that dramatically lowers cholesterolThe Verge
- FDA panel recommends approving Moderna COVID-19 vaccineNew York Post
- FDA targets early September for approving Pfizer's Covid-19 vaccinePOLITICO
- FDA Finally Gets Around to Approving Pfizer’s Anti-COVID Pillcapitolhilltimes.com
- US FDA chief defends process for approving COVID-19 vaccineThe Jerusalem Post (JPost.com)
- FDA panel recommends approving first peanut allergy treatmentThe Day
- MFDA to release conditions for approving COVID-19 vaccine--WSJmarketwatch.com
- A “disgraceful decision:” Researchers blast FDA for approving Alzheimer’s drugArs Technica
- FDA advisory committee recommends not approving Trevena pain drugbizjournals.com
- BSarepta Stock Is Spiking as FDA Reverses Course, Approving Drugbarrons.com
- U.S. Senators are Outraged by FDA Approving OxyContin for Children!salem-news.com
- Sapience Therapeutics ST-36 receives orphan drug designation from FDAwestfaironline.com
- MProQR shares rises on FDA orphan drug designationmarketwatch.com